Open an account

Cardlytics

CDLX · NASDAQ

$1.82−$0.025 (−1.36%)TodayMarket closed ·
Prev close $1.84

About CDLX

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. The company is headquartered in Atlanta, Georgia and currently employs 275 full-time employees. The company went IPO on 2018-02-09. Through the Cardlytics platform, its financial media network, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. The company maintains the Cardlytics platform in both the United States (U.S.) and United Kingdom (U.K.). The Cardlytics platform helps marketers find potential new customers that are active in their category but not shopping with them, or to grow their business with existing customers. The Cardlytics platform also provides its marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of its partners' customers. The Cardlytics platform helps solve fundamental problems for its financial institutions (FI partners).

Employees
275
Headquarters
Atlanta, Georgia
Listed
Feb 9, 2018
Sector
Communication Services
Industry
Media
Website
cardlytics.com

CDLX key statistics

Market cap
10.69M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
72.92K
Volume
44.69K
Open price
$1.82
High today
$1.92
Low today
$1.67
52 Week high
$21.70
52 Week low
$1.80

Cardlytics (CDLX) at a glance

Cardlytics (CDLX) last traded at $1.82, with a market cap of 10.69M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.67 and $1.92. The current price is 8.7% above the day's low and 5.5% below its high.

Volume so far is 44.69K shares, below the average of 72.92K shares a day.

Over the past year Cardlytics has ranged from $1.80 to $21.70, and now sits 0% of the way up that range.

Cardlytics met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported -$0.81 per share against an estimate of -$1.38.

The average analyst price target is $6.12, 237.2% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 6 analystsAvg $6.12
Low
$4.04
Now
$1.82
High
$10.50

CDLX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 57.4% on average.

  1. Q3 FY24: reported -$1.50 per share against an estimate of -$2.47
  2. Q4 FY24: reported $0.00 per share against an estimate of -$1.82
  3. Q1 FY25: reported -$2.10 per share against an estimate of -$2.37
  4. Q2 FY25: reported -$1.30 per share against an estimate of -$1.66
  5. Q3 FY25: reported -$0.70 per share against an estimate of -$1.53
  6. Q4 FY25: reported $0.30 per share against an estimate of -$0.714
  7. Q1 FY26: reported -$1.10 per share against an estimate of -$2.18
  8. Q2 FY26: reported -$0.81 per share against an estimate of -$1.38

CDLX news

  • Press releaseBusiness Wire

    Cardlytics and Rove Team Up to Help Travelers Earn Their Next Trip Faster

  • Press releaseBusiness Wire

    Similarweb Names Michael Akkerman as New Chief Executive Officer

  • Press releaseBusiness Wire

    Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

  • Press releaseBusiness Wire

    Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    Cardlytics Appoints Chris Cheng as Chief Legal Officer

  • Press releaseBusiness Wire

    Cardlytics to Report Second Quarter 2026 Results on August 5

  • Press releaseBusiness Wire

    Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance

  • Press releaseBusiness Wire

    Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Similar companies

Companies in the same industry as Cardlytics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.